Status: Recruiting
VNS Algorithm for Advanced Dosing
The goal of this clinical trial is to compare the standard programming of the VNS device (Control) to a modified programming (Augusta Way) in adults with epilepsy. The main question it aims to answer is: Does the modified programming of the VNS reduce seizures faster than the standard programming? Participants in both groups will: 1. Attend up to 3 study visits every 3 months for 2 years 2. Answer questionnaires to assess quality of life and cognitive function 3. Maintain a diary of seizure activity
Participants needed: 80
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Fernando ValeUpdated: Jul 24, 2026Locations: 1
Eligibility criteria
Subjects who are clinically determined to be candidates for VNS implantation for... [+1]
Subjects with VNS system treating pathologies other than drug refractory epileps...